EMA — authorised 14 August 2015
- Marketing authorisation holder: United Therapeutics Europe Ltd
- Status: approved
🇪🇺 Ch14.18 in European Union
EMA authorised Ch14.18 on 14 August 2015
Marketing authorisation
Ch14.18 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Ch14.18 approved in European Union?
Yes. EMA authorised it on 14 August 2015.
Who is the marketing authorisation holder for Ch14.18 in European Union?
United Therapeutics Europe Ltd holds the EU marketing authorisation.